E. Eigendorff
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Viral-associated cancers and disorders
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Hormonal Regulation and Hypertension 4
- Adrenal Hormones and Disorders 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Masahiro Tsuboi (2 shared papers)Heather A. Wakelee (2 shared papers)Ayman Samkari (2 shared papers)Moïshe Liberman (1 shared paper)Ke‐Neng Chen (1 shared paper)Olivier Bylicki (1 shared paper)Margarita Majem Tarruella (1 shared paper)Christophe Dooms (1 shared paper)
- Journals
- Hormone and Metabolic Research (2 papers)Annals of Oncology (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)ESMO Open (1 paper)Journal of Endocrinology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
E. Eigendorff
10 papers receiving 1.1k citations
E. Eigendorff's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 407
- Pulmonary and Respiratory Medicine 465
- Pathology and Forensic Medicine 116
- Endocrinology, Diabetes and Metabolism 101
- Otorhinolaryngology 19
Countries citing papers authored by E. Eigendorff
This map shows the geographic impact of E. Eigendorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Eigendorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Eigendorff more than expected).
Fields of papers citing papers by E. Eigendorff
This network shows the impact of papers produced by E. Eigendorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Eigendorff. The network helps show where E. Eigendorff may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Eigendorff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer Hit paper breakdown → | 2023 | 693 |
| 2 | Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2024 | 137 |
| 3 | 2002 | 134 | |
| 4 | 2018 | 102 | |
| 5 | 2004 | 23 | |
| 6 | 2020 | 22 | |
| 7 | 2003 | 8 | |
| 8 | 2010 | 5 | |
| 9 | 2016 | 1 | |
| 10 | 2026 | 1 | |
| 11 | 2012 | 0 |
About E. Eigendorff
E. Eigendorff is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Behavioral Neuroscience, Oncology and Genetics, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (4 papers), Adrenal Hormones and Disorders (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Estrogen and related hormone effects (2 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Lung Cancer Research Studies (1 paper) and Adrenal and Paraganglionic Tumors (1 paper). The work is most often cited by research in Oncology (407 citations), Pulmonary and Respiratory Medicine (465 citations), Pathology and Forensic Medicine (116 citations), Endocrinology, Diabetes and Metabolism (101 citations) and Otorhinolaryngology (19 citations). E. Eigendorff has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Masahiro Tsuboi, Heather A. Wakelee, Ayman Samkari, Moïshe Liberman, Ke‐Neng Chen, Olivier Bylicki, Margarita Majem Tarruella, Christophe Dooms, Jamie E. Chaft and Se‐Hoon Lee. Their work appears in journals such as Hormone and Metabolic Research, Annals of Oncology, The Journal of Clinical Endocrinology & Metabolism, ESMO Open and Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.